The primary endpoint was all-cause mortality or major stroke at 1 year.

The primary endpoint was overall response rate after four cycles of treatment.

However, no improvement was noted in the other primary endpoint, overall survival.

The primary endpoint was the absolute changes in ALT at 12 weeks.

The main endpoint was in-field lymphoma response at each irradiated disease site.

Conclusions: There was no between-group difference for the primary endpoint, headache episodes.

The primary endpoint in both studies was overall survival at 6 months.

The primary endpoint of our study was ongoing pregnancy within 6 months.

The primary efficacy endpoint was the progression-free survival rate at 3 months.

The primary endpoint was 5-year event-free survival; we also measured overall survival.

Secondary study endpoint included angiographic and safety endpoints such as hemorrhagic complications.

A stratified log-rank test was used to assess the primary endpoint, PFS.

Why the using of knowledge as an endpoint in study needs emphasis.

The primary endpoint was reported as the change in naloxone prescriptions dispensed.

Secondary endpoint was the combination of mortality and hospitalization within 3 months.

The main endpoint was the analysis of hepatic and intestinal DNA adducts.